While Afrezza is big, the crown jewel, IMHO, is MNKD's inhalable technology. Being able to formulate current pill medications into rabidly absorbed (esp ones sensitive to digestive degradation before it can even be absorbed) would be an even bigger game changer. Just think. Either a big pharma comes around to pay a huge premium for the tech or MNKD license the tech to other manufactures for nice fat profits.

I know mnkd still has to get to and cross the finish line with Afrezza but the possibilities are staggering with this company.